Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects.
AUTOR(ES)
Poewe, W
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1014364Documentos Relacionados
- Ultrasensitive TSH assay and anti-parkinsonian treatment with levodopa.
- Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response
- (+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.
- Bromocriptine in Parkinson's disease: a study of cardiovascular effects.
- Pharmacokinetics and Tolerability of Gemifloxacin (SB-265805) after Administration of Single Oral Doses to Healthy Volunteers